Galectin Therapeutics Reports Third Quarter 2015 Financial Results And Provides Business Update
NORCROSS, Ga. -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported financial results for the three ... Read News
RISK EVALUATION AND MITIGATION STRATEGY (REMS)
The YERVOY Immune-mediated Adverse Reaction Management Guide YERVOY (ipilimumab) is indicated for the treatment of unresectable or metastatic melanoma. ... Doc Viewer
Corporate Medical Policy Ipilimumab (Yervoy)
Ipilimumab (Yervoy) When Ipilimumab (Yervoy) is covered Ipilimumab is considered medically necessary for the treatment of unresectable or metastatic ... Visit Document
Ipilimumab (YERVOY™) - National Health Service
Antibodies > Ipilimumab (YERVOY™) Ipilimumab (YERVOY™) Ipilimumab, which is also known as YERVOY™. It is used to treat advanced melanoma (a type of skin cancer). Ipilimumab may also be used to treat other types of cancer as part of a research Ipilimumab: Drug Information (accessed ... Read Document
Finding Clinical Trials For Lung Cancer Treatment
Finding clinical trials for lung cancer can seem overwhelming. How do you begin to find a trial that meets your particular situation? ... Read Article
Yervoy-Med Guide - Bristol-Myers Squibb
31 . What is YERVOY? YERVOY is a prescription medicine used to treat a kind of skin cancer called melanomaYERVOY may . be used: • when your melanoma has spread or cannot be removed by surgery. ... Fetch This Document
YERVOY (Ipilimumab) - VCHCP - Home
Prior Authorization DRUG Guidelines YERVOY (Ipilimumab) metastatic melanoma. VCHCP requires that Yervoy be prescribed by an Oncologist. Dosing: Adult Melanoma, unresectable or metastatic: I.V.: 3 mg/kg every 3 weeks for 4 doses ... Retrieve Here
MRx Yervoy 08 15 ICD10 - Magellan Provider
Malignant Melanoma† o Must be used as a single agent; Absence of unacceptable toxicity from the drug. Examples of unacceptable toxicity include the following: Yervoy™ (ipilimumab) Prior Auth Criteria Proprietary Information. ... Get Content Here
FDA Approves YERVOY™ (ipilimumab) For The Treatment Of ...
FDA Approves YERVOY™ (ipilimumab) for the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer ... Fetch Content
Lisa On Melanoma Treatment Yervoy - YouTube
This feature is not available right now. Please try again later. Published on Mar 12, 2012. Lisa on Melanoma treatment Yervoy ... View Video
New Melanoma Drugs
On March 25, 2011, the FDA approved Yervoy (ipilimumab) for use in metastatic melanoma. It is likely that a secondnew drug will be approved by the end of 2011. The Melanoma Research Foundation (MRF) is playing a pivotal role in the ... Access This Document
Your Guide To Treatment With YERVOY (ipilimumab)
Against unresectable or metastatic melanoma cells. YERVOY works through your immune system. YERVOY does not kill melanoma directly. Instead, experimental drug. What was the goal of the YERVOY study? The major goal was to measure how long patients lived with ... Return Document
Yervoy. Prior Authorization Criteria
Yervoy . Prior Authorization Group: Yervoy. Drug Names: Yervoy. Covered Required Medical Information: Clinically diagnosed Stage III/IV unresectable or metastatic melanoma. Life expectancy of at least 4 months. Must submit baseline TSH, AST, ALT, Total bilirubin. ... Content Retrieval
Health Alliance: Yervoy (ipilimumab)
Progression of melanoma with prior Yervoy therapy.4 YERVOY ALGORITHM Deny Referral for Yervoy Is the disease unresectable, recurrent, or metastatic? Will clinical chemistries including LFTs and thyroid function tests be evaluated at baseline and ... Fetch Document
YERVOY - Food And Drug Administration
YERVOY safely and effectively. melanoma. (1) -----DOSAGE AND ADMINISTRATION----- • YERVOY 3 mg/kg administered • Inspect parenteral drug products visually for particulate matter and discoloration prior to administration. ... Get Doc
FDA Approves Opdivo And Yervoy Combination For Advanced ...
FDA Approves Opdivo and Yervoy Combination for Advanced Melanoma Statement from Tim Turnham, Executive Director, Melanoma Research Foundation Ippy/Nivo Drug Approval Statement Author: Jen Keywords: drug approval ; statement Created Date: ... Fetch Full Source
Ipilimumab, A Human Monoclonal Antibody For Treatment Of ...
Ipilimumab, a Human Monoclonal Antibody for Treatment of Unresectable or Metastatic Melanoma Published on Cancer Network (http://www.cancernetwork.com) Approved Drug: Ipilimumab (Yervoy) Indications ... Document Viewer
Interferon - Melanoma Skin Cancer Treatment With Interferon
Learn more about interferon-alfa2b, the only approved drug for the adjuvant (post-surgery) treatment of patients with high-risk melanoma in danger of recurring (coming back). ... Read Article
ORAL DRUGS FOR METASTATIC MELANOMA
ORAL DRUGS FOR METASTATIC MELANOMA DRUG CLASS: Oncology – Kinase Inhibitors BRAND (generic) NAMES: • Tafinlar (dabrafenib) 50 mg, 75 mg capsules • Mekinist (trametinib) 0.5 mg, 1 mg, 2 mg tablets (Yervoy), Mekinist, or ... View This Document
Yervoy - European Medicines Agency
Yervoy . Procedural steps taken and scientific information after the authorisation . melanoma. Consequently, sections 4.1, 4.2, 4.5, 4.8, add two quality control testing sites for Yervoy drug product and changes in the quality control testing ... Document Viewer
Ipilimumab - Wikipedia
L'ipilimumab, nome commerciale Yervoy, prodotto dalla Bristol-Myers Squibb. È un anticorpo monoclonale IgG1κ interamente umano approvato nel 2011 dalla FDA per il trattamento del melanoma avanzato (metastatico o inoperabile) in soggetti adulti e sui quali siano state provate altre terapie. ... Read Article
No comments:
Post a Comment